Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T15:11:47.242Z Has data issue: false hasContentIssue false

Further studies with quadruple vaccine

Published online by Cambridge University Press:  15 May 2009

David S. Dane
Affiliation:
Department of Microbiology, The Queen's University of Belfast, Northern Ireland
Margaret Haire
Affiliation:
Department of Microbiology, The Queen's University of Belfast, Northern Ireland
George Dick
Affiliation:
Department of Microbiology, The Queen's University of Belfast, Northern Ireland
E. Moya Briggs
Affiliation:
Department of Microbiology, The Queen's University of Belfast, Northern Ireland
T. J. Connor
Affiliation:
Department of Microbiology, The Queen's University of Belfast, Northern Ireland
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Reactions to the pertussis component of the original commercial batches of quadruple vaccine against poliomyelitis, diphtheria, tetanus and pertussis (Quadrilin, Glaxo Laboratories) gave some cause for concern. Severe reactions were found to be more common in infants under 6 months of age than in older infants.

A modified quadruple vaccine, which has been used in N. Ireland since October 1964, was found to give rise to significantly fewer and milder reactions. This vaccine when given in three doses separated by intervals of 6–9 weeks and 6 months to fifty-eight infants most of whom were 6–7 months of age at the start of immunization was found to give a satisfactory immunological response.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 1966